Oragenics Inc (OGEN)
1.44
+0.04
(+2.86%)
USD |
NYAM |
Mar 28, 16:00
1.42
-0.02
(-1.39%)
After-Hours: 20:00
Oragenics Cash from Operations (TTM): -8.621M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -8.621M |
June 30, 2023 | -10.89M |
March 31, 2023 | -11.70M |
December 31, 2022 | -15.23M |
September 30, 2022 | -15.28M |
June 30, 2022 | -16.08M |
March 31, 2022 | -14.78M |
December 31, 2021 | -13.47M |
September 30, 2021 | -14.62M |
June 30, 2021 | -14.70M |
March 31, 2021 | -17.46M |
December 31, 2020 | -16.95M |
September 30, 2020 | -17.26M |
June 30, 2020 | -15.97M |
March 31, 2020 | -14.62M |
December 31, 2019 | -13.01M |
September 30, 2019 | -12.05M |
June 30, 2019 | -11.13M |
March 31, 2019 | -9.924M |
December 31, 2018 | -9.080M |
September 30, 2018 | -7.461M |
June 30, 2018 | -6.346M |
March 31, 2018 | -5.83M |
December 31, 2017 | -6.364M |
September 30, 2017 | -6.969M |
Date | Value |
---|---|
June 30, 2017 | -7.201M |
March 31, 2017 | -7.356M |
December 31, 2016 | -7.075M |
September 30, 2016 | -6.773M |
June 30, 2016 | -6.497M |
March 31, 2016 | -5.521M |
December 31, 2015 | -5.190M |
September 30, 2015 | -4.709M |
June 30, 2015 | -4.511M |
March 31, 2015 | -5.263M |
December 31, 2014 | -5.559M |
September 30, 2014 | -5.598M |
June 30, 2014 | -6.464M |
March 31, 2014 | -6.768M |
December 31, 2013 | -6.764M |
September 30, 2013 | -7.286M |
June 30, 2013 | -6.50M |
March 31, 2013 | -5.650M |
December 31, 2012 | -5.212M |
September 30, 2012 | -4.862M |
June 30, 2012 | -5.203M |
March 31, 2012 | -5.514M |
December 31, 2011 | -5.495M |
September 30, 2011 | -5.875M |
June 30, 2011 | -5.752M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-17.46M
Minimum
Mar 2021
-8.621M
Maximum
Sep 2023
-13.88M
Average
-14.62M
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
OPKO Health Inc | -28.20M |
Palatin Technologies Inc | -26.54M |
Inogen Inc | -3.234M |
Cyclacel Pharmaceuticals Inc | -16.11M |
MAIA Biotechnology Inc | -13.07M |